Emerging in the arena of obesity treatment, retatrutide represents a different approach. Unlike many current medications, retatrutide functions as a dual agonist, simultaneously engaging both glucagon-like peptide-1 https://poppyytui134283.designertoblog.com/69800680/the-new-retatrutide-the-glp-gip-receptor-agonist